Menopause The Journal of The North American Menopause Society · 2018 · 17 citations · 26 references
MedicineImmunologyNutritional SciencesClinical ImmunologyInflammationWomen's HealthCytokine BiologyMicronutrient SupplementationVitamin DVitamin D MetabolismVitamin PhysiologyVitamin SupplementationAmenorrhea TreatmentMenstrual AmenorrheaOral SupplementationPlacebo-controlled Efficacy AssessmentSerum 25-Hydroxyvitamin D StatusTherapeutic Vitamin D SupplementationVitamin D BiomarkersVitamin D Status Biomarkers
OBJECTIVE: The aim of this study was to evaluate the effect of vitamin D (VitD) supplementation on immune-inflammatory biomarkers in younger postmenopausal women. METHODS: In this double-blind, placebo-controlled trial, 160 postmenopausal women aged 50 to 65 years with amenorrhea ≥12 months were randomized into two groups: VitD group, oral supplementation with 1000 IU VitD3/day (n = 80) or placebo group (n = 80). The intervention time was 9 months, and the women were assessed at baseline and endpoint. Serum levels of interleukins (ILs)-1β, IL-5, IL-6, IL-10, IL-12ρ70, IL-17α, tumor necrosis factor-alpha, and interferon-gamma were determined by immunoassay. Plasma concentrations of 25-hydroxyvitamin D [25(OH)D] were measured by high-performance liquid chromatography. Per-protocol analysis was adopted as the statistical method using a gamma distribution and repeated measures design, followed by Wald's multiple comparisons test. RESULTS: The two groups were similar at baseline in terms of clinical and laboratory parameters. After 9 months, there was a significant increase of 25(OH)D levels in the VitD group (+45.4%, P < 0.001) and a decrease (-18.5%, P = 0.049) in the placebo group. A significant decrease in IL-5, IL-12p70, IL-17α, tumor necrosis factor-alpha, and interferon-gamma levels was observed in the VitD group (P < 0.05). IL-5 and IL-6 levels were significantly lower in the VitD group compared to the placebo group (P < 0.05). There were no significant intervention effects on serum IL-1β or IL-10 levels in either group (P > 0.05). CONCLUSIONS: In younger postmenopausal women, isolated supplementation with 1000 IU of VitD3 for 9 months was associated with a reduction in proinflammatory biomarkers.
26
Scott M. Grundy · JAMA · 1993 · 27.9K citations
Evaluation Expert Panel on Detection · JAMA · 2001 · 26K citations
Medicine, Cardiology, Otolaryngology +10
Decreased bioavailability of vitamin D in obesity
Jacobo Wortsman, Lois Y. Matsuoka, Tai C. Chen et al. · American Journal of Clinical Nutrition · 2000 · 3.2K citations · Full text
Vitamin D Deficiency and Risk of Cardiovascular Disease
Thomas J. Wang, Michael J. Pencina, Sarah L. Booth et al. · Circulation · 2008 · 2.4K citations · Full text